cis-Hydroxy praziquantel
CAS : 134924-68-8
Ref. 3D-FH24095
| 1mg | Arrêté | ||
| 2mg | Arrêté | ||
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté |
Informations sur le produit
Nom :
cis-Hydroxy praziquantel
Synonymes :
- 1,2,3,6,7,11b-Hexahydro-2-[(cis-4-hydroxycyclohexyl)carbonyl]-4H-pyrazino[2,1-a]isoquinolin-4-onecis-(+/-)-1,2,3,6,7,11b-Hexahydro- 2-[(4-hydroxycyclohexyl)carbonyl]- 4H-pyrazino[2,1-a]isoquinolin-4-one
- 4H-Pyrazino(2,1-a)isoquinolin-4-one, 1,2,3,6,7,11b-hexahydro-2-((4-hydroxycyclohexyl)carbonyl)-
Description :
cis-Hydroxy praziquantel is an anthelmintic drug that is used in the treatment of tapeworms. It is a prodrug that is metabolized to praziquantel, its active form, by cytochrome P450 enzymes in the liver. cis-Hydroxy praziquantel can be administered orally and has been shown to have an uptake rate of about 20% when incubated in rat plasma. The pharmacologic effects are primarily due to the enantiomer of cis-Hydroxy praziquantel, as the molecule has a dipole with a positive charge on one end and a negative charge on the other. cis-Hydroxy praziquantel has been shown to have cardiotoxic effects at high dosages, which may be due to its ability to inhibit cardiac potassium channels.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
328.41 g/mol
Formule :
C19H24N2O3
Degré de pureté :
Min. 95%
InChI :
InChI=1S/C19H24N2O3/c22-15-7-5-14(6-8-15)19(24)20-11-17-16-4-2-1-3-13(16)9-10-21(17)18(23)12-20/h1-4,14-15,17,22H,5-12H2
Code InChI :
InChIKey=OKTGUGBZQBTMHZ-UHFFFAOYSA-N
SMILES :
O=C(C1CCC(O)CC1)N1CC(=O)N2CCc3ccccc3C2C1
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
